SAN DIEGO -- Treatment with hydroxyurea led to more hematologic dose-limiting toxicities (DLTs) compared with placebo in ...
Sotagliflozin, a dual SGLT1/2 inhibitor, increased hemoglobin levels in patients with type 2 diabetes and chronic kidney ...
Beam Therapeutics (BEAM – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Yanan Zhu ...
AABB guidelines overall favor a restrictive transfusion strategy, recommending RBC transfusion for hemoglobin <7 g/dL for the ...
The majority of SCD patients given Lyfgenia in clinical trials remained free of vaso-occlusive events (VOEs) following ...
"The education was not there. It still isn't there, but it should be," Alvin Henry Jr., a sickle cell disease patient, said. ...
A new trial called BEACON, led at Boston Childrens Hospital by Dr. Matthew Heeney and sponsored by Beam Therapeutics, is testing base editing as a way to boost fetal hemoglobin production in patients ...
Neonatal anemia can have lasting impacts on the growth and development of children. Anemia is highly prevalent among pregnant ...
Columnist Oluwatosin Adesoye addresses some of the myths about blood transfusion and explains why it's important in managing ...
Hemoglobin is important because it lets your red blood cells carry oxygen to all parts of your body. Because of this, people with this condition may have anemia, which is when you have too few ...
The following is a summary of “Erythrocyte indices and response to hypoxia-inducible factor prolyl hydroxylase inhibitors in ...
Promising topline results from a phase 3B study show the efficacy and quality of life (QOL) improvements of iptacopan ...